NOVOCURE LIMITED Business Segments NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.61 USD | -2.28% |
|
+2.21% | +17.95% |
| 09-03 | NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor | MT |
| 09-03 | Novocure Announces CEO Changes, Effective January 1, 2025 | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Surgical & Medical Equipment | 351M | 494M | 535M | 538M | 509M | |||||
Total Assets | 479M | 1.05B | 1.14B | 1.19B | 1.15B | |||||
Interest Expense | -13.87M | -17.66M | -3.44M | -3.33M | -3.32M | |||||
Income Tax Expense | -1.59M | -1.71M | 6.28M | 10.69M | 15.3M | |||||
CAPEX | -10.48M | -14.97M | -24.17M | -21.36M | -27.09M | |||||
EBT | -8.82M | 18.1M | -52.08M | -81.85M | -192M | |||||
Gross Profit | 263M | 388M | 420M | 423M | 381M | |||||
D&A | 6.78M | 7.75M | 9.17M | 9.57M | 9.7M | |||||
Operating Income | -914K | 30.4M | -44.33M | -89.52M | -233M | |||||
Net Income | -7.23M | 19.81M | -58.35M | -92.53M | -207M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 233M | 341M | 353M | 407M | 350M | |||||
Total Assets | 8.9M | 11.87M | 23.26M | 30.01M | 41.63M | |||||
Total Assets | 2.75M | 4.37M | 5.3M | 7.18M | 8.32M | |||||
Total Assets | 3.07M | 2.85M | 4.08M | 5.08M | 7.73M | |||||
Germany | 86.56M | 93.26M | 93.94M | 46.12M | 60.21M | |||||
Total Assets | 729K | 1.08M | 1.02M | 762K | - | |||||
Other International Markets | - | - | - | - | 44.49M | |||||
Total Assets | 1.58M | 1.23M | 1.15M | 1.26M | 5.18M | |||||
Japan | 17.91M | 29.08M | 34.64M | 32.78M | 31.67M | |||||
Total Assets | - | 1.23M | 799K | 1.06M | - | |||||
Greater China | 5.26M | 12.59M | 22.76M | 21.33M | 23.22M | |||||
Europe, Middle East and Africa (EMEA) (Excluding Germany) | 8.78M | 18.65M | 30.58M | 30.71M | - | |||||
Europe, Israel and Japan | - | - | - | - | - | |||||
Europe, Middle East and Africa (EMEA) | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- NVCR Stock
- Financials NovoCure Limited
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition